Na Li Zixuan Wan Dongyan Lu Ruilian Chen Xiaowei Ye
10.3389/fimmu.2022.1088683
Front Immunol
2023 Jan 10;13:1088683.
high microsatellite instability (msi-h) high tumor mutational burden immunotherapy mismatch repair deficiency squamous lung cancer
CC BY
https://pubmed.ncbi.nlm.nih.gov/36703977/
Carcinoma, Non-Small-Cell Lung / genetics Carcinoma, Non-Small-Cell Lung / therapy Carcinoma, Squamous Cell Lung Neoplasms / genetics Lung Neoplasms / therapy
Carcinoma, Non-Small-Cell Lung / genetics Carcinoma, Non-Small-Cell Lung / therapy Carcinoma, Squamous Cell Lung Neoplasms / genetics Lung Neoplasms / therapy Review Case Reports Research Support, Non-U.S. Gov't DNA Mismatch Repair / genetics Humans Immune Checkpoint Inhibitors Immunotherapy Microsatellite Instability Immune Checkpoint Inhibitors Turcot syndrome
PMC9871463
36703977
Long-term benefit of immunotherapy in a patient with squamous lung cancer exhibiting mismatch repair deficient/high microsatellite instability/high tumor mutational burden: A case report and literature review
2023